Re: Opinion: Here’s your guide to the upcoming biotechnology takeover wave
Yes, we may see more M&A before end of month. The quote appears to come from CEO Ken Frazier at JPM. Will be interesting to see who they end up buying.
“Ken Frazier:
It’s got a very high elevation. I think it’s helpful that valuations have begun to come down. We continue to look for those assets that we believe can create value for our shareholders and then I think it becomes more possible with more recent valuations. We’re very active. I think the fact that you haven’t seen a large deal coming out of Merck recently is not a reflection of the fact that we’re not looking at those.
When I say large, I mean an important deal not necessarily large from a size standpoint. We are active. We’ve actually tried to consummate some deals. They haven’t worked because we haven’t had a willing seller or the asset was too robustly competitive because it was a late-stage asset. But broadly speaking I think with the valuations coming down, it creates more possibilities.”
https://seekingalpha.com/article/4231943-merck-and-co-inc-mrk-jpmorgan-healthcare-conference-transcript